POMGNT2, protein O-linked mannose N-acetylglucosaminyltransferase 2 (beta 1,4-), 84892
N. diseases: 63; N. variants: 17
Source: ALL
Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
0.925 | 3 | 43080674 | missense variant | G/A | snv | 1.6E-05 |
|
0.800 | 1.000 | 1 | 2015 | 2015 | |||||||||
|
1.000 | 3 | 43080959 | missense variant | C/T | snv | 1.2E-05 |
|
0.800 | 0 | ||||||||||||
|
3 | 43106160 | upstream gene variant | C/G;T | snv |
|
0.700 | 1.000 | 2 | 2018 | 2018 | |||||||||||
|
1.000 | 0.040 | 3 | 43083698 | intron variant | C/T | snv | 0.17 |
|
Neoplasms | 0.700 | 1.000 | 1 | 2017 | 2017 | |||||||
|
1.000 | 0.040 | 3 | 43083989 | intron variant | C/T | snv | 0.16 |
|
Neoplasms | 0.700 | 1.000 | 1 | 2017 | 2017 | |||||||
|
1.000 | 0.040 | 3 | 43097822 | intron variant | G/C | snv | 3.9E-02 |
|
Neoplasms | 0.700 | 1.000 | 1 | 2017 | 2017 | |||||||
|
1.000 | 0.040 | 3 | 43090125 | intron variant | A/T | snv | 0.16 |
|
Neoplasms | 0.700 | 1.000 | 1 | 2017 | 2017 | |||||||
|
1.000 | 0.040 | 3 | 43098498 | intron variant | C/T | snv | 1.9E-02 |
|
Neoplasms | 0.700 | 1.000 | 1 | 2017 | 2017 | |||||||
|
1.000 | 0.040 | 3 | 43092956 | intron variant | G/A;C | snv | 0.16 |
|
Neoplasms | 0.700 | 1.000 | 1 | 2017 | 2017 | |||||||
|
1.000 | 0.040 | 3 | 43079343 | 3 prime UTR variant | T/G | snv | 0.11 |
|
Neoplasms | 0.700 | 1.000 | 1 | 2017 | 2017 | |||||||
|
0.925 | 0.080 | 3 | 43090952 | intron variant | C/T | snv | 0.79 |
|
Neoplasms | 0.700 | 1.000 | 1 | 2017 | 2017 | |||||||
|
0.925 | 0.080 | 3 | 43090952 | intron variant | C/T | snv | 0.79 |
|
Infections | 0.700 | 1.000 | 1 | 2009 | 2009 | |||||||
|
1.000 | 0.040 | 3 | 43084913 | intron variant | C/T | snv | 0.59 |
|
Neoplasms | 0.700 | 1.000 | 1 | 2017 | 2017 | |||||||
|
1.000 | 0.040 | 3 | 43087416 | intron variant | A/T | snv | 0.95 |
|
Neoplasms | 0.700 | 1.000 | 1 | 2017 | 2017 | |||||||
|
1.000 | 0.040 | 3 | 43091527 | intron variant | C/A;T | snv |
|
Neoplasms | 0.700 | 1.000 | 1 | 2017 | 2017 | ||||||||
|
1.000 | 3 | 43080687 | stop gained | G/A | snv |
|
0.700 | 0 | |||||||||||||
|
1.000 | 3 | 43080938 | missense variant | A/G | snv |
|
0.700 | 0 | |||||||||||||
|
0.925 | 3 | 43080674 | missense variant | G/A | snv | 1.6E-05 |
|
0.700 | 0 | ||||||||||||
|
1.000 | 3 | 43080099 | stop gained | G/A;T | snv | 4.0E-06; 4.0E-06 |
|
0.700 | 0 | ||||||||||||
|
1.000 | 3 | 43080959 | missense variant | C/T | snv | 1.2E-05 |
|
Nervous System Diseases | 0.700 | 0 | |||||||||||
|
1.000 | 3 | 43080959 | missense variant | C/T | snv | 1.2E-05 |
|
Pathological Conditions, Signs and Symptoms; Female Urogenital Diseases and Pregnancy Complications | 0.700 | 0 |